Free Trial

Ocular Therapeutix (OCUL) Insider Trading & Ownership

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)
Free OCUL Stock Alerts
$4.74
+0.54 (+12.84%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Ocular Therapeutix (NASDAQ:OCUL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.50%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$7.02 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$198,963.46
Get OCUL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ocular Therapeutix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OCUL Insider Buying and Selling by Quarter

Ad Behind the Markets
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>

Ocular Therapeutix Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/26/2024Summer Road LlcMajor ShareholderBuy930,851$7.52$6,999,999.52  
1/31/2024Antony C MattessichCEOSell18,338$4.95$90,773.10  
1/31/2024Donald NotmanCFOSell6,433$4.95$31,843.35  
1/31/2024Philip C StrassburgerGeneral CounselSell6,831$4.95$33,813.45  
1/31/2024Rabia Gurses OzdenInsiderSell7,764$4.95$38,431.80  
8/30/2023Antony C MattessichCEOBuy6,500$3.81$24,765.00  
7/7/2023Rabia Gurses OzdenInsiderSell832$4.93$4,101.76  
(Data available from 1/1/2013 forward)

OCUL Insider Trading Activity - Frequently Asked Questions

Who is on Ocular Therapeutix's Insider Roster?

The list of insiders at Ocular Therapeutix includes Antony C Mattessich, Christopher G White, Donald Notman, Philip C Strassburger, Rabia Gurses Ozden, Richard L Md Lindstrom, and Summer Road Llc. Learn more on insiders at OCUL.

What percentage of Ocular Therapeutix stock is owned by insiders?

5.50% of Ocular Therapeutix stock is owned by insiders. Learn more on OCUL's insider holdings.

Which Ocular Therapeutix insiders have been buying company stock?

The following insiders have purchased OCUL shares in the last 24 months: Antony C Mattessich ($24,765.00), and Summer Road Llc ($7,749,999.52).

How much insider buying is happening at Ocular Therapeutix?

Insiders have purchased a total of 1,103,479 OCUL shares in the last 24 months for a total of $7,774,764.52 bought.

Which Ocular Therapeutix insiders have been selling company stock?

The following insiders have sold OCUL shares in the last 24 months: Antony C Mattessich ($174,169.66), Christopher G White ($24,714.96), Donald Notman ($59,301.59), Philip C Strassburger ($60,020.89), and Rabia Gurses Ozden ($42,533.56).

How much insider selling is happening at Ocular Therapeutix?

Insiders have sold a total of 78,353 Ocular Therapeutix shares in the last 24 months for a total of $360,740.66 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:OCUL) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
They say it’s ‘unstoppable’ – How I made 43,509%
Investing Daily
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace